Probiotec Limited’s Acquisition of Australian Blister Sealing (ABS)

Arnold Bloch Leibler advised ASX-listed Probiotec Limited, on its acquisition of leading pharmaceutical business Australian Blister Sealing (ABS).

Probiotec is a manufacturer, marketer and distributor of a diverse, high quality range of prescription and over-the-counter pharmaceuticals and complementary medicines. ABS is a 40 year old pharmaceutical and consumer products contract packer, with the capability to pack a wide range of formats for the pharmaceutical, cosmetic and food industries.

ABS was established in Hornsby in 1979 to provide a contract packaging service to Australian manufacturing industries.

Led by Corporate and M&A Partner Jeremy Lanzer (Picture), the cross-practice team advising Probiotec included Anna Sandiford and Karri Walker (Corporate and M&A), Gia Cari, Ben Worth and Sam Scheinberg (Property) and Bridget Little and Emily Gray (Workplace Advisory).

Involved fees earner: Gia Cari – Arnold Bloch Leibler; Jeremy Lanzer – Arnold Bloch Leibler; Bridget Little – Arnold Bloch Leibler;

Law Firms: Arnold Bloch Leibler;

Clients: Probiotec Limited;

Author: Michael Patrini